![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
![]() | |
Company type | Public |
---|---|
Industry | Medical Device, Science and Technology |
Founded | 2013 |
Founder | Dr Faz Chowdhury |
Headquarters | Loughborough , United Kingdom |
Website |
nemauramedical |
Nemaura Medical Inc. is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBeAT. [1] [2] [3] [4] [5]
The company was founded by Dr. Faz Chowdhury in 2013. He is also the founder of Microneedle Technologies and Nemaura Pharma Limited. It is headquartered in Loughborough, United Kingdom. [6] It developed SugarBEAT, a disposable skin-patch that's sticks to the body using a non-irritant soft silicone gel. The skin-patch connects to a rechargeable transmitter which detects blood sugar and transfers the data to a mobile app at a 5-minute interval. The lifespan of the transmitter is 2 years and the skin patch can be used for 24 hours. [7] [8] [9] [4] The skin patch has an approximate thickness of 1mm. Electronic currents are used to draw interstitial fluid to the surface which analyses the glucose level. [10] [11] [12]
Sugarbeat underwent European clinical trial program with 16, Type I and Type II diabetic patients in 2017. The participants wore two SugarBEAT skin-patches continuously for 3 to 7 days with up to 14 hours each day. [7] [13] The study yielded positive results. [7] [1] [14] The first model of SugarBEAT is wired to a smartwatch and received CE approval in February, 2016. [15]
Nemaura signed a marketing rights agreement with Dallas Burston Pharma (Jersey) Ltd to market SugarBEAT in the UK and Ireland. [16]
Nemaura is listed on NASDAQ since January 2018 as NMRD. [17] [18] However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023). [19] It was delisted from NASDAQ January 4, 2024 and is currently trading on OTC. [20]
SugarBeat is expected to be launched by 2018 in UK followed by Europe, Middle East and Australia. [17] [4]